Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11692024 Methods of treating AL amyloidosis

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
March 5, 2020
0
Date of Patent
July 4, 2023
0
Patent Application Number
16810319
0
Patent Citations
‌
US Patent 8105594 Methods for amyloid removal using anti-amyloid antibodies
0
‌
US Patent 8263746 Anti-CD38 human antibodies and uses thereof
0
‌
US Patent 9249226 Antibodies against human CD38
0
‌
US Patent 9364542 Protein formulations containing amino acids
0
‌
US Patent 10046050 Targeting immunotherapy for amyloidosis
0
‌
US Patent 9884020 Antibody formulations and methods for treating AL amyloidosis
0
‌
US Patent 10766965 Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
0
‌
US Patent 7829673 Antibodies against CD38 for treatment of multiple myeloma
0
‌
US Patent 7928203 Chimeric, humanized, or human antibody 2A4
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11692024
0
Patent Primary Examiner
‌
Olga N. Chernyshev
0
CPC Code
‌
C07K 16/18
0
‌
C07K 2317/24
0
‌
A61B 5/0205
0
‌
A61K 9/0019
0

Find more entities like US Patent 11692024 Methods of treating AL amyloidosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.